CLOTILDIA is a single-center, prospective, randomized, open label, cross-over study
evaluating the effects of ticagrelor versus high-dose clopidogrel on endothelial function and
platelet reactivity in patients with type-2 diabetes mellitus (T2DM) treated with
percutaneous coronary intervention (PCI).